date,title,source
Oct-26-18,Karyopharm Therapeutics Announces Management Change,GlobeNewswire
Oct-29-18,Karyopharm Therapeutics Announces Closing of Additional $22.5 Million of 3.00% Convertible Senior Notes Due 2025 Pursuant to Exercise in Full of Initial Purchasers Option,GlobeNewswire
Oct-31-18,Is Karyopharm Therapeutics Inc (NASDAQ:KPTI) Potentially Underrated?,Simply Wall St.
Nov-01-18,Karyopharm Announces Results of Clinical Studies Investigating Selinexor in Multiple Myeloma and Diffuse Large B-Cell Lymphoma to be Presented at the American Society of Hematology 2018 Annual Meeting,GlobeNewswire
Nov-01-18,"Karyopharm to Report Third Quarter 2018 Financial Results on November 8, 2018",GlobeNewswire
Nov-05-18,Karyopharm Therapeutics to Ring Nasdaq Closing Bell on November 6th,GlobeNewswire
Nov-07-18,Karyopharms Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma,GlobeNewswire
Nov-07-18,Karyopharm to Present at the Jefferies 2018 London Healthcare Conference,GlobeNewswire
